Abstract

Herein, a photoelectrochemical (PEC) aptasensing platform was designed by integrating surface oxygen vacancy (OV) defects, Ti3+ self-doping, the heterojunction, and resonance energy transfer (RET) effect into one platform for the detection of diclofenac sodium (DCF). Briefly, OV defects were introduced on TiO2 nanospheres with simultaneous Ti3+ self-doping, followed by a well-separated deposition of FeVO4 nanoparticles on TiO2 to obtain a Ti3+-O-TiO2/FeVO4 heterojunction. The surface modification of OVs, Ti3+ doping, and deposition of FeVO4 were confirmed by SEM, XPS, EPR, DRS, and PEC measurements. The surface OVs and doping of Ti3+ species created a new donor (defect) energy level under the conduction band of TiO2, which minimized the bandgap and thereby improved the visible light absorption of TiO2. Moreover, the capture of photo-excited electrons by surface OVs could hinder the electron-hole recombination. Due to the intimate surface contact and perfect energy matching between TiO2 and FeVO4, the formation of heterojunction decreased the bandgap and facilitated the electron-hole separation of TiO2. All these above events contributed to the enhancement of the PEC signals, which were then quenched by the RET effect between Ti3+-O-TiO2/FeVO4 and Au nanoparticle (AuNP)-labeled cDNA that had been attached to its complementary DCF aptamer on Ti3+-O-TiO2/FeVO4|ITO. The addition of target-DCF detached AuNP-labeled cDNA from the electrode to recover the photocurrent, resulting in a "signal-on" PEC aptasensor that exhibited a 0.1-500-nM linear range and a detection limit of 0.069nM for DCF, attributed to the excellent amplification of the proposed aptasensing platform.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.